NCT Number: NCT02634450
Early Infant Diagnosis Point of Care Pilot
In Mozambique, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories in Maputo, Nampula, Beira and Quelimane. However, test volumes are growing and many parts of the country do not have close access to laboratories. Test samples are transported over large distances and this can introduce testing delays, especially for patients in rural and remote areas of the country. There are now new POC EID technologies becoming available that will enable diagnosis of HIV in infants within minutes or a couple of hours on site in the clinic, operated by non technical staff and without laboratory infrastructure. This protocol describes a plan to conduct an evaluation of a Point-Of-Care (POC) Early Infant Diagnosis (EID) testing technologies that are being considered for use in Mozambique, and to pilot those technologies in order to provide more effective diagnostics and clinical care to patients. During this implementation pilot, sites are randomized to use either conventional or POC EID testing only before the inclusion of the patients in the study. No consent will be asked to the parents or guardians. A written permission will be asked to the Direção Provincial de Saúde of both provinces to implement the POC device as routine in those intervention sites. All the information that will be analyzed will be collected from the routine care and it will be analyzed as a group.
Looking for future studies?
Notify MeKey information
Age range
4 week–18 month
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Centro de Saude Moamba, Moamba, Maputo Province, Mozambique
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Born to HIV positive mother
- From 4 weeks to 18 months of age
- Came to CCR consultation for Early Infant Diagnosis
Exclusion criteria
- With a valid positive test by other center
Treatment and study plan
Primary outcomes
-
The proportion of HIV-positive infants initiating antiretroviral therapy within 60 days of sample collection
Time frame: up to 6 months
-
the proportion of HIV-positive infants who initiated antiretroviral therapy that were retained in care at 90 days of follow-up.
Time frame: 3 months after treatment initiation
Patients were considered retained in care at 90 days if they had visited the health facility within the previous 30 days.
Secondary outcomes
-
The median age at time of results received by patient
Time frame: Up to 6 months
-
The median number of days between specimen collection and results received by patient
Time frame: Up to 6 months
-
The median age at time of antiretroviral treatment initiation
Time frame: Up to 6 months
-
The median number of days between specimen collection and initiation of antiretroviral treatment.
Time frame: Up to 6 months
Sponsors and collaborators
Lead sponsor
Instituto Nacional de Saúde, Mozambique
Other Gov
Collaborators
- Clinton Health Access Initiative Inc.
- UNICEF
- UNITAID
Registry information
Official study title
Evaluation of Point-Of-Care Testing Assays for Early Infant in Mozambique-Cluster Randomised Trial
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Dec 18, 2015
- Registry last updated
- Jul 26, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Contingency Management in HIV Care for Both Stimulant Use & ART Adherence
NCT06564792
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
San Francisco, California, United States
View Trial DetailsValidation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)
NCT04121026
Actinomycetales Infections, Bacterial Infections
Abidjan, Côte d’Ivoire
View Trial DetailsHome Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)
NCT01161446
Behavior, Blood-Borne Infections
Seattle, Washington, United States
View Trial DetailsImproving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)
NCT01331811
Actinomycetales Infections, Bacterial Infections
Bobo-Dioulasso, Burkina Faso
View Trial Details